Sign up Australia
Proactive Investors - Run By Investors For Investors

XTEK secures cash in oversubscribed capital raising

A share purchase plan will follow the $3 million oversubscribed placement.
XTEK secures cash in oversubscribed capital raising
Shares in XTEK are up over 55% in 2017

XTEK (ASX:XTE) has completed a $3.0 million oversubscribed placement to sophisticated and institutional investors priced at $0.46 per share.

Eligible shareholders will also have the opportunity to participate in a share purchase plan (SPP) at the same issue price to raise an additional $0.5 million taking the total raising to $3.5 million.

Funds raised will be used to accelerate the development and commercialisation of XTEK’s XTclave™ and XTatlas™ technologies, and to provide working capital for growth from major contract wins.

Philippe Odouard, managing director, commented: “We are pleased by the considerable support shown during this equity raising.

“It reflects a strong endorsement from the investment community and XTEK’s shareholders and places the company in a very strong position to accelerate the growth of the business and to benefit from the global trend of increased government spending on security equipment and technology in the face of growing global uncertainty.”


XTEK is a leader in homeland security equipment for the military and police sectors.

The supply and maintenance of small unmanned aerial systems (SUAS) is becoming a major focus for XTEK.

In addition, XTEK has developed a range of new technologies which it is now commercialising for the international market.

XTclave™ composite protection products and XTatlas™ real-time geospatial video provide novel solutions for western military forces.

Use of funds

Funds raised from the placement and SPP will be primarily used for:

- XTclave commercialisation: including the construction of XTEK’s own commercial scale XTclave production plant and ancillary equipment, allowing XTEK to continue the promotion of its technology on the world market. This will allow XTEK to produce commercial quantities of its advanced XTclave personal hard armour ballistic protection plates;
- XTatlas technology development: the commercialisation of XTatlas through its existing and future unmanned aircraft system contracts is a key focus for the company;
- Expansion capital: to allow the achievement of revenue guidance and pursue more and larger contracts in the future; and
- Costs of the placement and SPP.

SPP timetable

The proposed timetable for the placement and SPP is as follows:

- 27 June: Record date for SPP;
- 30 June: Settlement of placement;
- 3 July: SPP booklet despatched to shareholders; and
- 24 July: SPP closes.


The capital raising provides XTEK with the necessary funding to continue its strong momentum in 2017, which has seen the share price rise over 65% to $0.55.

XTEK is well positioned with Australian federal and state governments increasing their spending on security equipment during these uncertain times.

This is highlighted by the company’s recent $1.7 million contract for the supply of two explosive ordnance disposal (EOD) robots to a state police force.

Furthermore, XTEK is well placed to secure additional sales contracts as robots used by Australian law enforcement agencies are approaching the end of their useful lifecycle and will need to be either upgraded or replaced.

View full XTE profile View Profile

XTEK Ltd Timeline

Related Articles

An energy plant
August 13 2018
The exclusive contract will run its course for two years and includes a one -year extension option
An illustration of the tools Velpic uses in providing education and incident management
March 22 2018
Velpic has just signed its first NowForce client in Australia.
Data servers
July 31 2018
The company is expected to list on the main board of the LSE in September

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use